Mitral Regurgitation Surveillance Variation
Examining these issues is critical because echocardiography is performed at continually increasing rates. [11] [12] [13] The delivery of a variety of health services has been shown to vary significantly across providers and patients. 11, [14] [15] [16] Given the balance between timeliness of surveillance and possible overutilization of TTE in valvular disease, we assessed the association of surveillance frequency for MR with specific provider factors. The variation in performance of all-cause TTEs has been associated with local practice patterns and urban and rural settings, but little is known about specific causes of variation. 11, 17, 18 To understand how to improve quality and value in echocardiography for patients with MR, we sought to determine the degree of variation in patient care and to investigate patient and provider factors contributing to variation in TTE utilization. We hypothesized that there was variation attributable to provider practice even after adjustment for patient characteristics.
Methods

Data Source
The Massachusetts General Hospital (MGH) is the largest hospital in New England. The MGH Echocardiography Laboratory maintains a database of all echocardiograms performed in the main and satellite laboratories, including ordering provider, patient identifiers, and granular clinical data, such as MR severity and LV size. This database was linked with hospital billing data for patient demographic characteristics.
Study Population
The study population included all patients >18 years of age who underwent at least 2 inpatient or outpatient TTEs between 2001 and March 2016. All TTEs are visible to all care providers within the system through a shared electronic health record. TTEs are ordered through the electronic medical system, and results are automatically sent to the ordering provider.
Outcomes and Covariates
The primary outcome was the number of months (intervals) between 2 consecutive studies done on a given patient. For a given patient, TTEs were assessed sequentially. The interval in months was calculated between TTEs, associated with the severity of MR in the initial TTE of each interval, and attributed to the provider who ordered the later study.
Intervals for patients in the echocardiography database not in the billing database were excluded from the analysis because demographic data could not be linked with the patient. Studies done on patients with an ejection fraction <50% were excluded, to eliminate those not represented by the American College of Cardiology/American Heart Association guidelines. 2 We excluded those with dilated LVs, any wall motion abnormalities, and those with MR mechanisms of incomplete closure or tethering without mitral valve prolapse to exclude those with secondary MR. 19 To exclude studies on patients following valve replacement or repair, we excluded any interval marked by a persistent decrease in severity of valvular disease after moderate or severe disease. The validity of this strategy to exclude patients with interval surgery was confirmed by direct physician chart review of a selection of patients excluded by this algorithm. To exclude intervals during which patients may have been receiving echocardiography outside our hospital, we also excluded any echo intervals >72 months. Consecutive inpatient TTEs and intervals with a single inpatient TTE after an outpatient TTE were also excluded. All ordering providers were identified as a cardiologist, primary care physician (PCP), or other specialist as of the time of the analysis by linkage with an administrative database. Missing data on provider type were adjudicated manually by physicians at the hospital (Drs Tanguturi and Wasfy). Most physicians are faculty physicians and few (≈1%) are in private practice. Five providers for whom a field of practice could not be identified were excluded from the study. Providers who had ordered <5 tests were excluded from the initial cohort because these providers were unlikely to be providing longitudinal care. When additional exclusion criteria were applied, additional providers were seen to have ordered <5 TTEs. TTEs ordered by these providers were aggregated and grouped under a dummy provider.
Demographic variables included age, sex, self-reported race, estimated income, and distance from the echocardiography facility. Race was recorded as white, non-Hispanic black, Hispanic, Asian, and other. Patient age was calculated as the difference between date of birth and the test date. Age was assessed as a categorical variable divided by decade starting at age 45 given a nonlinear distribution. Estimated income was used as a continuous variable, and distance from MGH was specified per 10 miles. The most recent zip code was used to estimate distance and income. For missing values of distance, the median distance was used, and for distances >90 miles, 90 miles was used. Income was inferred from zip code by US census data. 20 For missing income, we used the median income for the entire sample. Clinical variables included the change in LV end systolic dimension of the 2 prior TTEs, right-ventricular systolic pressure, left atrial size, presence of other valvular disease (moderate or severe aortic stenosis or insufficiency), and severity of MR (trace, mild, moderate, or severe). Changes in LV end systolic dimension, right-ventricular systolic pressure, and left atrial size were used as continuous variables. In addition, secular trend was measured by number of years starting from 2001 and specified as a continuous variable to account for trends over time. Provider factors were specialization and experience (estimated by the number of years a provider ordered TTEs).
Statistical Analysis
The length of interval TTE follow-up was modeled as a function of patient and provider factors. Frequencies and percentages were used to summarize the distribution of patients by categorical demographics. Means with SDs were used to summarize continuous variables. The outcome variable was right skewed, so a generalized mixed-effects linear regression model with gamma distribution and log link was used.
We controlled for the patient factors age, sex, race, estimated income, distance from the echocardiography facility, right-ventricular systolic pressure, left atrial size, presence of multiple valvular diseases, and change in LV end systolic dimension. Provider specialty and provider experience were the variables of interest. Regression results are reported as rate ratios (RRs) with 95% confidence intervals (CIs).
The contribution of the individual provider on the outcome variable was assessed by shrinkage estimates from a model with only patient factors to assess providers in comparison with the average provider. An SD and 95% CI was constructed around the shrinkage estimate for a given provider. If significantly higher than average, the provider was assigned to a group of providers with longer intervals, and if the estimate was significantly lower than average, the provider was assigned to a group of providers with shorter intervals.
An intraclass correlation coefficient (ICC) was calculated to estimate how much of the variation in intervals were because of provider factors. The ICC was compared from 2 models, 1 including patient factors and secular trend alone, and another adding provider factors.
All statistical analyses were performed using SAS, version 9.4 (SAS Institute, Inc, Cary, NC). This study was performed for the purposes of quality improvement, so was considered exempt from review by the Institutional Review Board at Partners Healthcare per the institutional review board policies. As a retrospective analysis of clinical data, informed consent was not required. Mitral Regurgitation Surveillance Variation
Sensitivity and Supplementary Analyses
To assess the robustness of our results with respect to care outside this healthcare system, we performed the same analysis in a cohort of patients predicted to receive the majority of their care at MGH. This loyalty cohort was determined by a logistic regression model that includes patient age, time since the most recent visit, in-state residency, physician practice style, and PCP or primary care practice association. The resulting model has been previously validated with a specificity of 93.7% and positive predictive value of 96.5%. 21 Additional sensitivity analyses were performed excluding inpatient TTEs and excluding patients with multiple valve disease. To examine the possibility that other imaging tests, such as transesophageal echocardiograms (TEEs), magnetic resonance imaging, stress echocardiography, or invasive catheterization, could have replaced some TTEs in following MR, we also conducted a direct physician chart review of a random sample of 100 patients in the analysis to determine how often other tests were ordered to follow MR.
Results
We initially evaluated 127 576 patients with 223 168 TTEs and 8879 providers. After application of the inclusion and exclusion criteria, 55 773 TTEs remained, resulting in 37 843 intervals in 17 930 patients ordered by 635 providers were in the analytic cohort ( Figure 1 ). Characteristics of the echocardiograms and providers are in Table 1 . Trace MR was seen in 23 150 study intervals (61.2%), mild MR in 10 348 (27.3%), moderate MR in 3678 (9.7%), and severe MR in 667 (1.8%). Seventeen percent of patients were seen to have vegetations, leaflet thickening, mitral valve prolapse, or rheumatic valve disease as markers of primary MR. Patients with moderate or severe MR were older, but other demographic variables were similar among different degrees of MR. The mean interval between TTEs was 12.4, 17.0, 18.3, and 17.4 months for severe, moderate, mild, and trace MR, respectively. Most studies done on patients with trace or mild MR were done sooner than would be indicated by the valvular disease (86.7% and 86.2%, respectively). Cardiologists ordered the majority of tests in our study population, and especially in patients with severe MR, ordering 89.5% of those studies and 80.1%, 69.9%, and 62.4%, in those with moderate, mild, and trace MR, respectively.
Association With Patient and Provider Factors
With increased severity of MR, there was a decrease in the interval between TTEs (P<0.0001; Table 2 Table 2 .
For mild MR, PCPs ordered TTEs every 28.2 months, cardiologists ordered TTEs every 17.4 months, and noncardiology specialists ordered TTE every 12.1 months (P<0.001; Figure 2 ). For moderate MR, PCPs ordered TTEs every 24.2 months, cardiologists ordered TTEs every 16.1 months, and noncardiac specialists ordered TTEs every 12.8 months (P<0.001). For severe MR, PCPs ordered TTEs every 20.5 months, whereas cardiologists ordered TTEs at a mean interval of every 11.8 months, and other specialists ordered studies every 10.0 months (P<0.001). For noncardiac specialists, mean time interval between studies trended less with MR severity (12.1 months for mild, 12.8 months for moderate, and 10.0 months for severe). For both cardiologists and PCPs, MR severity trended with shorter time intervals.
Sensitivity Analyses
A sensitivity analysis replicating the model in our loyalty cohort showed results that were largely consistent with the main findings of the primary analysis. When excluding inpatient studies, the ordering patterns of noncardiology specialists became significant. They were seen to order studies more frequently (RR, 0.781; 95% CI, 0.631-0.966). Other results were consistent and supported the main conclusions. Exclusion of those with multiple valve diseases showed results in keeping with the primary analysis. Full results are reported in the Appendix in the Data Supplement.
Supplementary Analyses
A direct physician chart review of a selection of 100 random patients at each severity of MR was conducted to Figure 1 . Cohort patients and study design. MGH indicates Massachusetts General Hospital; and TTE, transthoracic echo. Mitral Regurgitation Surveillance Variation assess the effect of TEEs, stress echocardiograms, cardiac catheterization, and magnetic resonance imagings. We were reassured to see that 1 of 100 had a stress echocardiogram that may have contributed to surveillance, and 1 of 100 had a TEE that may have been used in surveillance. No patients received magnetic resonance imagings. Most TEEs and all cardiac catheterizations were performed immediately before operations, and postop TTEs were excluded from our study.
Association Between Individual Provider and TTE Interval
Providers grouped by case-mix adjusted time intervals are shown in Figure 3 . High-frequency providers, or those with on average short intervals between TTEs, ordered TTEs at 8.9-month intervals for mild MR and 10.3-month intervals for severe MR, thus, independent of MR severity. Average frequency providers ordered TTEs at 20.6 months for mild MR and 11.0 months for severe MR, trending with MR severity. Low-frequency providers ordered TTEs for patients with mild MR every 30.2 months but for patients with severe MR every 18.9 months. Whereas mean intervals were all longer, intervals maintained correlation with severity of MR.
The proportions of high-and low-frequency providers by specialty are in Figure 4 . Among cardiologists, 25.2 of 180 (14%) had intervals longer than the mean for all providers, and 38 of 180 (21%) had intervals that were shorter. Among noncardiac specialists, 87 of 229 (38%) had intervals shorter than the mean, and 23 of 229 (10%) had longer Guideline recommendations used were 3 to 5 y for mild and trace MR, 1 to 2 y for moderate MR, and 6 to 12 mo for severe MR. 2 IQR indicates interquartile range; LA, left atrial; LVESD, left ventricular end systolic dimension; MR, mitral regurgitation; n, number of observations; PCP, primary care physician; RVSP, right-ventricular systolic pressure; and TTE, transthoracic echocardiogram. Mitral Regurgitation Surveillance Variation intervals. Among PCPs, 5 of 226 PCPs (2%) had intervals shorter than the mean, and 113 of 226 providers (50%) had longer intervals.
The ICC for the unadjusted data was 0.35 (Table 3) . When adjusted for patient factors alone, the ICC increased to 0.36. When adjusted for both patient factors and provider specialty and experience, the ICC decreased to 0.27.
Discussion
The surveillance of patients with chronic MR has both the potential for overutilization and underutilization and, as such, is an important case to study variation in the delivery of healthcare services. 3, 9 In this work, we demonstrate substantial variation in the receipt of surveillance TTEs and the association of individual provider practice patterns with interval TTE surveillance of patients with MR. Specifically, cardiologists were seen to order more frequent TTEs in general, whereas PCPs were seen to order TTEs less frequently than indicated, and in both fields, specific providers consistently tracked as over-or underutilizers.
Cardiologists were associated with the majority of the observations (66.6%). Mean imaging intervals for cardiology patients with moderate and severe MR were within guideline recommendations, but trace MR and mild MR were imaged more frequently than recommended. 2 Although we cannot determine the indications for all of these studies, it is unlikely that all of the observations ordered by cardiologists in patients with trace or mild MR can be accounted for by other illnesses requiring TTEs approximately every 18 months (Figure 2 ). Amongst cardiologists, there is also significant variation. Most cardiologists (64%) ordered within the average interval, but 21% of cardiologists fall into the provider group of those ordering TTEs with shorter intervals, and 14% of cardiologists ordered TTEs with longer intervals (Figure 4 ). This left shift of interval distribution and overall higher frequency than PCPs even after adjusting for patient factors is consistent with prior findings that specialists order more diagnostic testing. 22 Whereas a greater portion of cardiologists' tests was ordered for severe MR than the PCPs' practice panel, this increased frequency when compared with PCPs is maintained after controlling for disease severity.
In comparison with cardiologists, PCPs ordered TTEs at ≈50% longer intervals for all degrees of MR (Table 2) . Studies for those with trace or mild MR remained outside of guideline-recommended windows but were less frequent than those ordered by cardiologists. 2 However, patients with severe MR were also imaged less frequently than guideline recommendations 2 ( Figure 2) . Few PCPs had patients with studies that were done more frequently than the mean provider with only 2% of PCPs falling into the provider group with shorter intervals. Most PCPs (98%) were ordered within the average range or at longer intervals (Figure 4) .
In contrast, other specialists, including infectious disease specialists, oncologists, and pulmonologists, ordered TTEs at stable, and overall shorter, intervals, despite MR severity (Figure 2 ). This suggests that these specialists may not have been ordering studies to assess MR but rather to answer a different question with an independent time frame. These nearly yearly intervals suggest that these TTEs were spaced around yearly office visits, rather than on clinically guided intervals.
Provider experience was associated with ordering TTEs less frequently (Table 2) . A limitation to assessing provider experience is that we are only capturing ordering practice at MGH during our study period. We are unable to account for experience a provider may have had at another institution or if a provider's clinical volume changed drastically over time.
Variance related to providers was much more substantial than variance related to patient factors (Table 3 ). The association of interval echo imaging with experience and specialty provides guidance to reduce unwanted practice provider behavior in comparison with peers can be used to encourage both over-and underutilizers to examine ordering behavior.
One notable strength of our study is that by linking demographic data to an echocardiography database, we were able to assess granular information about patient characteristics that possibly influenced time intervals. Although a significant proportion of the observed variation was associated with provider factors, some patient factors were also significant ( Table 2 ). For example, Hispanic patients had longer imaging intervals than white patients, which warrants further investigation. The source of this variation, whether related to bias in ordering behavior, patient access to TTEs, or other factors, is unclear but warrants additional investigation because a patient's care should be consistent between providers. Secular trend noted that intervals elongated slightly over time, which suggests that initiatives to decrease overuse of TTE may be contributing to ordering patterns. Of note, increased distance from the hospital was significantly associated with longer surveillance interval, but the magnitude of that association effect was small. Because this association was not statistically significant in the loyalty cohort sensitivity analysis, this small effect may have been related to patients who live far away from the hospital receiving TTEs outside our system. Our analysis should be interpreted in the setting of important limitations. First, because of the need for granular information on severity of valvular disease, the analysis was performed within a single healthcare center. However, we think that because the MGH is a large general hospital, our results are likely generalizable to other settings. Second, because we are unable to capture TTEs performed at other hospitals, patients with fragmented care, who travel south during winter, or simply outside cardiologists, may receive echocardiography at different medical centers causing overestimation of time intervals for those patient and provider groups. Nevertheless, we are reassured that a sensitivity analysis performed in a validated loyalty cohort supported our main study findings. Third, we did not include a comorbidity index. However, there is no data to reliably suggest how comorbidities would affect the ordering of outpatient TTEs. Specifically, our analysis did not include information about atrial fibrillation, which could have changed ordering patterns. To adjust the conclusions of our analysis, patients with atrial fibrillation would have had to be distributed unequally among physicians with different ordering patterns. In addition, we are unable to assess the addition of medications for treatment of the sequelae MR because of limitations of our data sources. We are reassured that cardiologists, most likely to add these medications, still have frequent testing, suggesting that adding medications may not have had a significant effect on decreasing the frequency of testing. Other imaging, including TEEs, stress echocardiograms, and magnetic resonance imagings, that might have been used for MR surveillance was not part of our database leading to falsely elongated intervals. However, we are reassured by the results of our supportive direct chart review which demonstrated only a trivial number of instances in which another test was used intermittently to follow MR. We are, therefore, reassured that these other studies did not have a significant effect on our results. Last, it is possible that studies deemed to have been ordered sooner than indicated for valvular assessment were ordered for alternative assessments. However, whereas these indications, such as device adjustment, other valvular disease, or aortic aneurysms, may be over-represented in indications for TTEs ordered by cardiologists, they are unlikely to have a differential effect within each specialty. We are reassured that differences in provider practices persisted in patients with severe MR, who were most likely imaged primarily for their valvular disease. Finally, a sensitivity analysis excluding those with multiple valvular diseases further supported our main findings.
In conclusion, there is substantial variation the frequency of TTE assessment of MR among different physicians even after adjustment for patient factors. Ordering TTEs too frequently may reduce value in echocardiography, and not ordering TTEs often enough may lead to poor patient outcomes because of ventricular remodeling. We think these findings offer opportunities to improve both quality and value in echocardiography. In our study, provider-related variation is associated with specialization and provider experience, which are fortunately practical targets to minimize unwanted variation in patient care. These results may provide guidance for tactics to improve quality and value in the care of patients with MR, and suggest the need for further investigation into the causes of practice variation.
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